Atlanta Braves outfielder Jurickson Profar is set to begin a minor league rehab assignment, marking a significant step toward his return to the major league roster. Profar, who was suspended for 80 games due to a positive test for human chorionic gonadotropin (hCG), a banned performance-enhancing substance, is eligible to return to the Braves on June 29 against the Philadelphia Phillies.
The suspension has been a setback for the Braves, who signed Profar to a three-year, $42 million contract in January, anticipating his contribution to an outfield trio alongside Ronald Acuña Jr. and Michael Harris II. Profar’s absence has been felt, especially with Acuña Jr. sidelined due to injury. The Braves have had to rely on players like Jarred Kelenic and Bryan De La Cruz, but their performances have been underwhelming.
Profar’s rehab assignment is crucial not only for his return but also for the Braves’ lineup depth. His 2024 season with the San Diego Padres was impressive, earning him an All-Star selection and a Silver Slugger award. With a .280 batting average, 24 home runs, and 85 RBIs, Profar demonstrated his offensive capabilities.
As the Braves approach the midpoint of the season, Profar’s return could provide a much-needed boost to their outfield. However, questions remain about whether his past performance was influenced by the PEDs, and how he will reintegrate into the team’s dynamics. The Braves will be closely monitoring his progress during the rehab assignment to assess his readiness for a major league return.
